| Page 1179 | Kisaco Research

Restrictions on data usage and transfer vary significantly across the globe. Notable examples such as GDPR and CCPA garner headlines, but as efforts to regulate privacy proliferate globally organisations must adhere to an ever more fragmented series of rules. Could PETs help solve that challenge?

  • Determining what cross-border PET implementation looks like in practice
  • Understanding the regulatory perspective on PETs as a tool to build compliance for data in transit and use across borders
  • Understanding the necessary considerations to be made when forming both internal cross-border data sharing practices and external data sharing initiatives

Author:

Shashi Gowda

CEO
Devr

Shashi Gowda is CEO and co-founder of Devr and a member of its board of directors.  A seasoned technology leader and entrepreneur, Shashi brings over 20 years of experience in the telecommunications, big data and emerging tech industries.

 

Devr provides tools for enterprises to design and orchestrate data privacy, enabling rich open ecosystems for data monetization with continuous compliance.

 

Shashi champions advances in digital transformation, data privacy and continuous compliance using emerging technologies such as Blockchain and AI.  He is passionate about bringing technologies into highly regulated industries which enable them to innovate with data, in an era of growing privacy concerns, regulatory complexity, and high costs of non-compliance.

 

Before founding Devr, Shashi was CTO of Virtual Control and supported the sale of its AI and ML solutions to Agilent Technologies.  Prior to that, Shashi held various technology design and leadership roles, at both corporates and at early-stage companies, and has worked across Asia, Europe, and the US.

 

Shashi earned his bachelor’s degree in bio-medical engineering from Boston University.

Shashi Gowda

CEO
Devr

Shashi Gowda is CEO and co-founder of Devr and a member of its board of directors.  A seasoned technology leader and entrepreneur, Shashi brings over 20 years of experience in the telecommunications, big data and emerging tech industries.

 

Devr provides tools for enterprises to design and orchestrate data privacy, enabling rich open ecosystems for data monetization with continuous compliance.

 

Shashi champions advances in digital transformation, data privacy and continuous compliance using emerging technologies such as Blockchain and AI.  He is passionate about bringing technologies into highly regulated industries which enable them to innovate with data, in an era of growing privacy concerns, regulatory complexity, and high costs of non-compliance.

 

Before founding Devr, Shashi was CTO of Virtual Control and supported the sale of its AI and ML solutions to Agilent Technologies.  Prior to that, Shashi held various technology design and leadership roles, at both corporates and at early-stage companies, and has worked across Asia, Europe, and the US.

 

Shashi earned his bachelor’s degree in bio-medical engineering from Boston University.

Author:

Odvar Bjerkolt

Principal Lawyer - Data & Digital Transformation
BT Group

Odvar Bjerkolt

Principal Lawyer - Data & Digital Transformation
BT Group

Author:

John Bowman

Chief Privacy Office - AI Ethics Market Strategy Lead
IBM

John Bowman, joined IBM’s Chief Privacy Office in October 2022 with a primary mission to deliver client success and drive growth in IBM, including advising on enhancements to support regulatory compliance, helping to create a deployment framework, and commercialisation of select CPO assets.  Previously, John was a Senior Principal in Promontory, a Business Unit of IBM Consulting, having joined the company in 2014. John’s client engagements included managing privacy change programmes, preparing applications for Binding Corporate Rules, helping organisations prepare for regulatory audits, and advising on issues of risk, compliance, and public policy. Prior to joining Promontory, John worked at the UK Ministry of Justice where he was Head of EU and International Data Protection Policy. In this role, he served as the UK government’s lead negotiator on the EU General Data Protection Regulation (GDPR). John served on the International Association of Privacy Professionals (IAPP) European Advisory Board 2019-2020 and has over 25 articles published on privacy-related topics.

John Bowman

Chief Privacy Office - AI Ethics Market Strategy Lead
IBM

John Bowman, joined IBM’s Chief Privacy Office in October 2022 with a primary mission to deliver client success and drive growth in IBM, including advising on enhancements to support regulatory compliance, helping to create a deployment framework, and commercialisation of select CPO assets.  Previously, John was a Senior Principal in Promontory, a Business Unit of IBM Consulting, having joined the company in 2014. John’s client engagements included managing privacy change programmes, preparing applications for Binding Corporate Rules, helping organisations prepare for regulatory audits, and advising on issues of risk, compliance, and public policy. Prior to joining Promontory, John worked at the UK Ministry of Justice where he was Head of EU and International Data Protection Policy. In this role, he served as the UK government’s lead negotiator on the EU General Data Protection Regulation (GDPR). John served on the International Association of Privacy Professionals (IAPP) European Advisory Board 2019-2020 and has over 25 articles published on privacy-related topics.

Author:

Dr. June Brawner

Senior Policy Adviser for Data and Digital Technologies
The Royal Society

Dr. June Brawner is a policy advisor at The Royal Society, the UK’s national academy of sciences. She leads the Society’s work on Privacy Enhancing Technologies (PETs) within the Data and AI policy team, which is developing policy and promoting debate that helps the UK safely and rapidly realise the growing benefits of data science and digital technologies.

June’s career in academic and policy research spans the US, UK, and Central / Eastern Europe, with a focus on environmental data for policymaking.  Prior to her current role she worked as a research consultant and has previously completed fellowships with the Fulbright Commission and Columbia University’s Council for European Studies.

As an anthropologist, June is especially interested in the ‘social life’ of data: the cultural and political factors that hinder or promote the equitable use of data for research, innovation, and decision-making. To this end, she sees upholding the right to privacy as a key technical and social challenge in using data for societal benefit.

Dr. June Brawner

Senior Policy Adviser for Data and Digital Technologies
The Royal Society

Dr. June Brawner is a policy advisor at The Royal Society, the UK’s national academy of sciences. She leads the Society’s work on Privacy Enhancing Technologies (PETs) within the Data and AI policy team, which is developing policy and promoting debate that helps the UK safely and rapidly realise the growing benefits of data science and digital technologies.

June’s career in academic and policy research spans the US, UK, and Central / Eastern Europe, with a focus on environmental data for policymaking.  Prior to her current role she worked as a research consultant and has previously completed fellowships with the Fulbright Commission and Columbia University’s Council for European Studies.

As an anthropologist, June is especially interested in the ‘social life’ of data: the cultural and political factors that hinder or promote the equitable use of data for research, innovation, and decision-making. To this end, she sees upholding the right to privacy as a key technical and social challenge in using data for societal benefit.

Privacy- enhancing technologies have been demonstrated as technically effective- but that is not enough. Their implementation requires resource allocation, both in terms of acquiring the technology and subsequently monitoring it.

  • Establishing how PETs can deliver additional business value through unlocking previously inaccessible data
  • Practical first-hand examples successfully identifying relevant use cases, establishing proof of concept and seeing tangible return upon implementation
  • Learning how to quantifiably measure that return over time and assess the need for potential amendments or new areas of application

Author:

Dr. Walden “Wally” Rhines

President & CEO
Cornami

WALDEN C. RHINES is President & CEO of Cornami. He is also CEO Emeritus of Mentor, a Siemens business, focusing on external communications and customer relations. He was previously CEO of Mentor Graphics for 23 years and Chairman of the Board for 17 years. During his tenure at Mentor, revenue nearly quadrupled and market value of the company increased 10X.

Prior to joining Mentor Graphics, Dr. Rhines was Executive Vice President, Semiconductor Group, responsible for TI’s worldwide semiconductor business. During his 21 years at TI, he was President of the Data Systems Group and held numerous other semiconductor executive management positions.

Dr. Rhines has served on the boards of Cirrus Logic, QORVO, TriQuint Semiconductor, Global Logic and as Chairman of the Electronic Design Automation Consortium (five two-year terms) and is currently a director. He is also a board member of the Semiconductor Research Corporation and First Growth Children & Family Charities. He is a Lifetime Fellow of the IEEE and has served on the Board of Trustees of Lewis and Clark College, the National Advisory Board of the University of Michigan and Industrial Committees advising Stanford University and the University of Florida.

Dr. Rhines holds a Bachelor of Science degree in engineering from the University of Michigan, a Master of Science and PhD in materials science and engineering from Stanford University, a master of Business Administration from Southern Methodist University and Honorary Doctor of Technology degrees from the University of Florida and Nottingham Trent University.

Dr. Walden “Wally” Rhines

President & CEO
Cornami

WALDEN C. RHINES is President & CEO of Cornami. He is also CEO Emeritus of Mentor, a Siemens business, focusing on external communications and customer relations. He was previously CEO of Mentor Graphics for 23 years and Chairman of the Board for 17 years. During his tenure at Mentor, revenue nearly quadrupled and market value of the company increased 10X.

Prior to joining Mentor Graphics, Dr. Rhines was Executive Vice President, Semiconductor Group, responsible for TI’s worldwide semiconductor business. During his 21 years at TI, he was President of the Data Systems Group and held numerous other semiconductor executive management positions.

Dr. Rhines has served on the boards of Cirrus Logic, QORVO, TriQuint Semiconductor, Global Logic and as Chairman of the Electronic Design Automation Consortium (five two-year terms) and is currently a director. He is also a board member of the Semiconductor Research Corporation and First Growth Children & Family Charities. He is a Lifetime Fellow of the IEEE and has served on the Board of Trustees of Lewis and Clark College, the National Advisory Board of the University of Michigan and Industrial Committees advising Stanford University and the University of Florida.

Dr. Rhines holds a Bachelor of Science degree in engineering from the University of Michigan, a Master of Science and PhD in materials science and engineering from Stanford University, a master of Business Administration from Southern Methodist University and Honorary Doctor of Technology degrees from the University of Florida and Nottingham Trent University.

Author:

Lawrence Lundy-Bryan

Partner, Research
Lunar Ventures

Lawrence is a deep tech researcher and investor. He is a Partner for Research at Lunar Ventures, a deep tech venture fund where he focuses on horizon scanning. He developed stateofthefuture.xyz, a deep tech tracker, monitoring over 100+ technologies, and writes weekly stateofthefuture.substack.com. He published an investment thesis on privacy-enhancing technologies in 2021. He has previously advised the UK Government, EU Commission, and World Economic Forum on emerging technologies. 

Lawrence Lundy-Bryan

Partner, Research
Lunar Ventures

Lawrence is a deep tech researcher and investor. He is a Partner for Research at Lunar Ventures, a deep tech venture fund where he focuses on horizon scanning. He developed stateofthefuture.xyz, a deep tech tracker, monitoring over 100+ technologies, and writes weekly stateofthefuture.substack.com. He published an investment thesis on privacy-enhancing technologies in 2021. He has previously advised the UK Government, EU Commission, and World Economic Forum on emerging technologies. 

Author:

Robin Smith

Head, Cyber and Information Security
Aston Martin

Robin Smith

Head, Cyber and Information Security
Aston Martin

Author:

Nick New

Founder
Optalysys

Founded Optalysys in 2013 with twenty years experience in Fourier optical processing, having previously spun Cambridge Correlators Ltd. out of the University of Cambridge from technology developed during PhD in Optical Pattern Recognition.

Nick New

Founder
Optalysys

Founded Optalysys in 2013 with twenty years experience in Fourier optical processing, having previously spun Cambridge Correlators Ltd. out of the University of Cambridge from technology developed during PhD in Optical Pattern Recognition.

 

Adrelia Allen

Sr. Director, Clinical Trial Patient Diversity
Merck

Adrelia is a 23-year veteran of the pharmaceutical industry working in sales and clinical research at Merck.  She has held positions of increasing experience as a Clinical Research Associate, Clinical Trial Project Manager, and Clinical Research Manager.  She is currently, the Senior Director of Clinical Trial Patient Diversity where she leads a team of clinical trial operations experts focused on promoting inclusive research practices to support the enrollment of diverse patients in Merck clinical trials.  She is responsible for the execution and strategy implementation for clinical trial

Adrelia Allen

Sr. Director, Clinical Trial Patient Diversity
Merck

Adrelia Allen

Sr. Director, Clinical Trial Patient Diversity
Merck

Adrelia is a 23-year veteran of the pharmaceutical industry working in sales and clinical research at Merck.  She has held positions of increasing experience as a Clinical Research Associate, Clinical Trial Project Manager, and Clinical Research Manager.  She is currently, the Senior Director of Clinical Trial Patient Diversity where she leads a team of clinical trial operations experts focused on promoting inclusive research practices to support the enrollment of diverse patients in Merck clinical trials.  She is responsible for the execution and strategy implementation for clinical trial processes, resources, and training to help drive inclusion and access across our clinical trial portfolio.  Due to her commitment and determination to drive greater representation in clinical trials, Adrelia was recently selected as one of the 100 Most Inspiring People in the life sciences sponsored by PharmaVoice.

Adrelia earned a Doctor of Pharmacy degree from the College of Pharmacy at Florida A&M University.  She is a registered Pharmacist and a certified Project Management Professional. 

 

 

 

Joel Berry

Director of Biology
Felix Biotechnologies

Joel Berry

Director of Biology
Felix Biotechnologies

Joel Berry

Director of Biology
Felix Biotechnologies
 

Stephen Theriault

Chief Executive Officer & Chief Scientific Officer
Cytophage Technologies

Stephen Theriault

Chief Executive Officer & Chief Scientific Officer
Cytophage Technologies

Stephen Theriault

Chief Executive Officer & Chief Scientific Officer
Cytophage Technologies
 

Katherine Donovan

Lead Scientist, Fischer Lab
DFCI

Katherine Donovan is a Lead Scientist in the Fischer Lab where she works on the development of molecular-glues and PROTAC molecules for targeted protein degradation. After joining the Fischer Lab as a Postdoc she developed an interest in proteomics as a specialized technology for quantifying protein-level expression changes in response to various perturbations. Katherine set up and led proteomics teams focused on degrader screening and target identification in the Fischer Lab as well as in the Center for Protein Degradation.

Katherine Donovan

Lead Scientist, Fischer Lab
DFCI

Katherine Donovan

Lead Scientist, Fischer Lab
DFCI

Katherine Donovan is a Lead Scientist in the Fischer Lab where she works on the development of molecular-glues and PROTAC molecules for targeted protein degradation. After joining the Fischer Lab as a Postdoc she developed an interest in proteomics as a specialized technology for quantifying protein-level expression changes in response to various perturbations. Katherine set up and led proteomics teams focused on degrader screening and target identification in the Fischer Lab as well as in the Center for Protein Degradation. She has used proteomics technology to identify the degradation targets of many molecules including the identification of SALL4 as the protein likely underlying the teratogenicity of thalidomide. Katherine led a large effort to map the degradable kinome and now to aid her quest to map the degradable proteome she has recently started a public degradation proteomics initiative which provides free target mapping of degraders.

 

Fia Navntoft

Senior Clinical Project Manager
Molnlycke

Fia Navntoft

Senior Clinical Project Manager
Molnlycke

Fia Navntoft

Senior Clinical Project Manager
Molnlycke